Closed · CDC-RFA-GH21-2122 · CFDA 93.067 · Discretionary
Strengthen Capacity of South African Government's Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care (ACC) for Unstable HIV and TB/HIV Patients in the Republic of South Africa (SA) under PEPFAR
Federal grant opportunity posted by Centers for Disease Control - CGH, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- April 9, 2021
- Close date
- 2
- Expected awards
The verdict
Strengthen Capacity of South African Government's Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care (ACC) for Unstable HIV and TB/HIV Patients in the Republic of South Africa (SA) under PEPFAR is a closed discretionary listing from Centers for Disease Control - CGH that offered Varies by applicant across 2 expected awards. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 2
- expected awards
- 93.067
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Strengthen Capacity of South African Government's Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care (ACC) for Unstable HIV and TB/HIV Patients in the Republic of South Africa (SA) under PEPFAR - is cataloged under number CDC-RFA-GH21-2122 and tied to CFDA assistance listing 93.067, posted by Centers for Disease Control - CGH. Grants.gov currently shows the opportunity as closed, first posted on January 11, 2021 and last updated on March 24, 2021. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is Varies by applicant. It expects to issue 2 awards. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on April 9, 2021. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
April 9, 2021
Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Posted
January 11, 2021
Expected Awards
2
Instrument
Cooperative Agreement
Description
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,500,000 for Year 1, subject to the availability of funds.In SA, it is estimated that 20% of patients newly initiating anti-retroviral therapy (ART) present late and 10-15% of patients on first line ART are failing treatment, leading to poor retention, especially in the first 12 months of treatment. This NOFO seeks to decrease morbidity and mortality, improve treatment retention and viral load (VL) suppression of HIV and TB/HIV co-infected patients through the use of innovative capacity building approaches for health service providers to better manage complicated and unstable HIV and TB/HIV co-infected patients. Activities under this NOFO must include but are not limited to: building in-country capacity through in-person and other innovative capacity-building approaches in ACC to effectively manage complicated HIV and TB/HIV co-infected patients; building a cadre of local expertise through a Train the Trainer model; and using existing virtual platforms and technological tools to provide technical assistance (TA) to facility-based staff on management of complicated HIV and TB/HIV patients.Expected NOFO outcomes must include but are not limited to: increased competencies among health workers in providing appropriate services to manage complicated HIV and TB/HIV patients; improved quality of ACC services offered by the trained health care providers; and improved referral for genotypic testing services for eligible clients with VL failure.
Eligibility
Grants.gov lists this opportunity under eligibility category code 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Global AIDS
U.S. Department of Health and Human Services
Agency Contact
Emily Dale dln6@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |